 "Patanjali takes a u-turn; says never claimed to have made Covid-19 medicine")
Patanjali Ayurved on Tuesday said that it never claimed to have made medicine for coronavirus.
The Haridwar-based organisation has withdrawn from its earlier claim, in reply to the notice given by Uttarakhand Ayush Ministry.
"Patanjali has never claimed to make corona medicine. Rather, corona patients have been cured with this medicine. The drug was made under the license issued by the Ayush Ministry," stated the reply by Patanjali Ayurved CEO Acharya Balakrishna to the notice.
"We made the combination of Tulsi Giloy Ashwagandha at an advanced level and when the clinical trials were done on the patients of Covid-19, the coronavirus patients were cured. A conspiracy has been hatched against us and if the Ayush Ministry tells us to conduct clinical trials once again then we are ready to face it," he added.
Earlier in the month, Patanjali Ayurved, in collaboration with NIMS University, launched Coronil and Shwasari Vati, claiming to cure corona patients.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%